EmergingResearch compound

Nooglutyl

Russian AMPA-PAM research compound, plasticity enhancer.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

WHAT IS NOOGLUTYL?

Detailed overview

Nooglutyl (NSG, ONK-10, N-5-oxynicotinoyl-L-glutamic acid) is an experimental compound developed at the Pharmacology Institute of the Russian Academy of Sciences (Moscow), structurally related to Picamilon. AMPA receptor positive allosteric modulator – with substantially stronger AMPA binding affinity than Noopept (PMID 21476267). Unique data: benzodiazepine-withdrawal anxiety reduction in animal models without touching the GABA system; preservation of post-trauma mitochondrial oxidative phosphorylation (ATP-synthesis protection; PMID 9621180); anti-aging pro-cognitive effects in accelerated-aging models (PMID 18078032); enhanced neuroprotection when co-administered with Nimodipine. No human Phase data; rare on Western markets.

Mechanism

AMPA-PAM (glutamatergic)

Half-life

No published human data

Legal status

Russian preclinical only

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Limited human safety data: profile based mainly on animal studies and anecdotes
  • Mild anxiety and restlessness reported anecdotally (glutamatergic/stimulating character)
  • Physical stimulation and overstimulation at higher doses (above ~20 mg)
  • Theoretical risk typical of AMPA-enhancing compounds: headache, increased neuronal excitability
  • Sleep disturbance and difficulty falling asleep if taken in late afternoon or evening
  • Long-term safety unknown; chronic adverse effects not characterized

Contraindications · 5

  • Pregnancy and breastfeeding: no safety data, avoid
  • Epilepsy or low seizure threshold: AMPA/glutamatergic enhancement may theoretically raise seizure risk
  • Anxiety disorders: the stimulating character may worsen symptoms
  • Combining with other glutamatergic or stimulant nootropics requires caution (additive overstimulation)
  • Not an approved drug, no human dosing standard; research chemical only, use is experimental

Related Nootropics

Same therapeutic category

Telegram

Have a question about Nooglutyl?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.